Clinical Trials - REVB

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT06863467Evaluation of the Safety and Tolerability of Gemini in Subjects With Stage 3-4 Chronic Kidney Disease.RECRUITINGPHASE1, PHASE22025-01-202025-06-302025-06-30